Observational studyDiabetes, obesity & metabolism2019

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non-steroidal anti-inflammatory drugs.

Tetsuro Tsujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.